Headquartered in JLABS @ Toronto, in the MaRS Centre, the world’s largest urban innovation hub, where Avicanna’s scientists conduct research with world-class academic and clinical institutions including the University of Toronto.
Low cost, industrial scale cultivation and extraction infrastructure through Avicanna’s two subsidiaries in Santa Marta, Colombia, focused on organic and environmentally sustainable practices.
GMP manufacturing and a growing network of distributors around the world of our 4 key product categories of plant-derived cannabinoids, including:
▪ (i) pharmaceuticals;
▪ (ii) phyto-therapeutics;
▪ (iii) derma-cosmetics; and,
▪ (iv) cannabis extracts and purified cannabinoids.

A team of experienced management and scientific experts in the biopharmaceutical industry.